UMR_D 190, Emergence des Pathologies Virales, Aix-Marseille Univ., IRD French Institute of Research for Development, EHESP French School of Public Health, Marseille, France.
UMR_D 190, Emergence des Pathologies Virales, Aix-Marseille Univ., IRD French Institute of Research for Development, EHESP French School of Public Health, Marseille, France.
J Infect. 2014 Aug;69(2):182-9. doi: 10.1016/j.jinf.2014.03.016. Epub 2014 Apr 4.
The epidemiology of Influenza C virus (FLUCV) infections remains poorly characterised. Here, we have examined the age- and location-specific seroprevalence of antibodies against FLUCV in 1441 sera from metropolitan continental France (Marseille), South-West Indian Ocean French territories (Reunion Island) and United-Kingdom (Edinburgh) using a combination of haemagglutination inhibition, virus neutralisation and ELISA assays. Our results show that immunity to FLUCV is common in all locations studied (global seroprevalence values >50%) and that the first immunising contacts generally occur early in life (i.e., in the 0-4 year-old age group). The latter item is further supported by the detection of FLUCV RNA by RT-PCR in naso-pharyngeal samples collected in patient attending the Emergency Room of the Public hospitals of Marseille, France with a large majority of children under 10 years-old: 17 (60.7%) in children ≤3 yo, 10 (35.7%) in the 4-10 yo age group and 1 (3.6%) in an adult (49yo). The temporal distribution of cases was atypical with regard to influenza (a large proportion of cases occurred in spring and summer) and the clinical presentation was diverse, including but being not limited to classical Influenza-like-Ilnesses. Altogether, our results indicate an intense circulation of FLUCV in the different study areas and an early occurrence of infection in human life. Flu C appears to be a widely under-diagnosed and under-studied human paediatric disease that obviously deserves further clinical and epidemiological characterisation.
C 型流感病毒(FLUCV)感染的流行病学特征仍不清楚。在这里,我们使用血凝抑制、病毒中和和 ELISA 检测法,检测了来自法国大陆大都市(马赛)、西南印度洋法属领土(留尼汪岛)和英国(爱丁堡)的 1441 份血清样本中针对 FLUCV 的抗体的年龄和地理位置特异性血清阳性率。我们的结果表明,FLUCV 的免疫在所有研究地点都很常见(全球血清阳性率>50%),并且首次免疫接触通常发生在生命早期(即 0-4 岁年龄组)。这一点进一步得到了通过 RT-PCR 在法国马赛公立医院急诊室就诊的患者鼻咽样本中检测到的 FLUCV RNA 的支持:17 例(60.7%)为≤3 岁的儿童,10 例(35.7%)为 4-10 岁年龄组,1 例(3.6%)为成人(49 岁)。病例的时间分布与流感不同(很大一部分病例发生在春季和夏季),临床表现多样,包括但不限于典型的流感样疾病。总之,我们的结果表明,FLUCV 在不同的研究地区都在密集传播,并且在人类生命中很早就发生了感染。C 型流感显然是一种广泛被低估和研究不足的儿童疾病,显然值得进一步进行临床和流行病学特征描述。